|
    ABMD U.S.: Nasdaq

    Abiomed Inc.

    ABMDUS
    After Hours
    Last Updated: Oct 22, 2021 4:02 p.m. EDT Delayed quote

    $ 352.18

    0.00 0.00%
    After Hours Volume: 4.09K
    Close Chg Chg %
    $352.18 2.50 0.71%
    Advanced Charting
    Volume: 113.83K 65 Day Avg: 187.19K
    61% vs Avg
    346.24 Day Range 353.77
    242.73 52 Week Range 387.40

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ABMD Overview

    Performance

    5 Day
    • 0.23%
    1 Month
    • 0.52%
    3 Month
    • 7.20%
    YTD
    • 8.63%
    1 Year
    • 25.14%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 11 Full Ratings

    Recent News

    Read full story

    Abiomed Inc. stock rises Friday, outperforms market

    Read full story

    Abiomed Inc. stock rises Thursday, outperforms market

    Read full story

    Abiomed Inc. stock falls Wednesday, underperforms market

    Read full story

    Abiomed Inc. stock underperforms Tuesday when compared to competitors

    Read full story

    Abiomed Inc. stock outperforms competitors despite losses on the day

    Read full story

    Abiomed Inc. stock outperforms market on strong trading day

    Read full story

    Abiomed Inc. stock rises Thursday, outperforms market

    Read full story

    Abiomed Inc. stock rises Wednesday, outperforms market

    Read full story

    Abiomed Inc. stock outperforms competitors on strong trading day

    Read full story

    Abiomed Inc. stock outperforms competitors despite losses on the day

    Read full story

    Abiomed Inc. stock falls Friday, underperforms market

    Read full story

    Abiomed Inc. stock underperforms Thursday when compared to competitors despite daily gains

    Read full story

    Abiomed Inc. stock outperforms competitors on strong trading day

    Read full story

    Abiomed Inc. stock outperforms market on strong trading day

    Read full story

    Abiomed Inc. stock outperforms competitors despite losses on the day

    Read full story

    Abiomed Inc. stock falls Friday, underperforms market

    Read full story

    Abiomed Inc. stock falls Thursday, underperforms market

    Read full story

    Abiomed Inc. stock falls Wednesday, underperforms market

    Read full story

    Abiomed Inc. stock falls Tuesday, underperforms market

    Read full story

    Abiomed Inc. stock underperforms Monday when compared to competitors

    Abiomed (ABMD) to Report Q2 Earnings: What's in the Cards?

    on Zacks.com

    Earnings Preview: Abiomed (ABMD) Q2 Earnings Expected to Decline

    on Zacks.com

    What's in Store for Intuitive Surgical's (ISRG) Q3 Earnings?

    on Zacks.com

    Abiomed (ABMD) Stock Jumps 5.9%: Will It Continue to Soar?

    on Zacks.com

    Analysts Are Bullish on These Healthcare Stocks: Abiomed (ABMD), Amgen (AMGN)

    on TipRanks.com

    America’s Most Influential CEO Is Nvidia’s Jensen Huang

    on InvestorPlace.com

    Here's Why You Should Retain Abiomed (ABMD) Stock For Now

    on Zacks.com

    2 Hot Stocks to Buy and Hold Until You Retire

    on Motley Fool

    Abiomed (ABMD) Up 6% Since Last Earnings Report: Can It Continue?

    on Zacks.com

    Abiomed Inc (ABMD) Chairman, President, CEO Michael R Minogue Sold $1.2 million of Shares

    on GuruFocus.com

    Abiomed's (ABMD) Impella ECP Gets FDA's Breakthrough Device Tag

    on Zacks.com

    Here's Why You Should Retain Abiomed (ABMD) Stock for Now

    on Zacks.com

    Analysts Offer Insights on Healthcare Companies: Cigna (CI) and Abiomed (ABMD)

    on TipRanks.com

    Leerink Partners Keeps Their Hold Rating on Abiomed (ABMD)

    on TipRanks.com

    ABIOMED, inc (ABMD) Q1 2022 Earnings Call Transcript

    on Motley Fool

    Abiomed's (ABMD) Q1 Earnings and Revenues Beat, Margins Up

    on Zacks.com

    Analysts Offer Insights on Healthcare Companies: Abiomed (ABMD) and SQZ Biotechnologies (SQZ)

    on TipRanks.com

    Abiomed (ABMD) Beats Q1 Earnings and Revenue Estimates

    on Zacks.com

    Medical Products' Aug 5 Earnings Roster: BDX, RMD & More

    on Zacks.com

    Abiomed (ABMD) Reports Next Week: Wall Street Expects Earnings Growth

    on Zacks.com

    Abiomed Inc.

    ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA.

    Competitors

    Name Chg % Market Cap
    Medtronic PLC 1.18% $165.66B
    Stryker Corp. -0.26% $103.98B
    Boston Scientific Corp. -0.07% $63.85B
    Teleflex Inc. -0.47% $17.62B
    Boston Scientific Corp. 5.5% Pfd. Series A 0.65%
    Competitor Data Provided ByCapital Cube Logo